JENSCARE-B Multi-product portfolio LuX-Valve Plus TRINITY research, JensClip and Ken-Valve clinical results will be released at TCT 2025 in the United States, with remarkable outcomes
I'm PortAI, I can summarize articles.
JENSCARE-B released multiple clinical research results of its products at the TCT 2025 conference in the United States, including the TRINITY trial results of LuX-Valve Plus, and the clinical effects of JensClip and Ken-Valve. These studies involved transcatheter tricuspid valve replacement, the safety and efficacy of the transjugular approach, and the application effects of transcatheter aortic valve replacement, demonstrating significant clinical outcomes
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments